rs56148525

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_181078.3(IL21R):​c.1033G>A​(p.Gly345Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00387 in 1,613,242 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G345D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 9 hom. )

Consequence

IL21R
NM_181078.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 0.373

Publications

13 publications found
Variant links:
Genes affected
IL21R (HGNC:6006): (interleukin 21 receptor) The protein encoded by this gene is a cytokine receptor for interleukin 21 (IL21). It belongs to the type I cytokine receptors, and has been shown to form a heterodimeric receptor complex with the common gamma-chain, a receptor subunit also shared by the receptors for interleukin 2, 4, 7, 9, and 15. This receptor transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells. The ligand binding of this receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1, and STAT3. Knockout studies of a similar gene in mouse suggest a role for this gene in regulating immunoglobulin production. Three alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
IL21R-AS1 (HGNC:27551): (IL21R antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_181078.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034081936).
BP6
Variant 16-27448699-G-A is Benign according to our data. Variant chr16-27448699-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 225037.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181078.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL21R
NM_181078.3
MANE Select
c.1033G>Ap.Gly345Ser
missense
Exon 9 of 9NP_851564.1Q9HBE5
IL21R
NM_181079.5
c.1099G>Ap.Gly367Ser
missense
Exon 10 of 10NP_851565.4
IL21R
NM_021798.4
c.1033G>Ap.Gly345Ser
missense
Exon 9 of 9NP_068570.1Q9HBE5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL21R
ENST00000337929.8
TSL:1 MANE Select
c.1033G>Ap.Gly345Ser
missense
Exon 9 of 9ENSP00000338010.3Q9HBE5
IL21R
ENST00000395754.4
TSL:1
c.1033G>Ap.Gly345Ser
missense
Exon 9 of 9ENSP00000379103.4Q9HBE5
IL21R
ENST00000564089.5
TSL:5
c.1033G>Ap.Gly345Ser
missense
Exon 10 of 10ENSP00000456707.1Q9HBE5

Frequencies

GnomAD3 genomes
AF:
0.00265
AC:
404
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00231
AC:
578
AN:
250206
AF XY:
0.00244
show subpopulations
Gnomad AFR exome
AF:
0.000807
Gnomad AMR exome
AF:
0.00324
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00374
Gnomad OTH exome
AF:
0.00327
GnomAD4 exome
AF:
0.00400
AC:
5847
AN:
1460900
Hom.:
9
Cov.:
31
AF XY:
0.00399
AC XY:
2898
AN XY:
726760
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33480
American (AMR)
AF:
0.00376
AC:
168
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000612
AC:
16
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.000133
AC:
7
AN:
52478
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00482
AC:
5361
AN:
1111974
Other (OTH)
AF:
0.00441
AC:
266
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
352
704
1055
1407
1759
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00265
AC:
404
AN:
152342
Hom.:
0
Cov.:
33
AF XY:
0.00260
AC XY:
194
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41570
American (AMR)
AF:
0.00425
AC:
65
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00426
AC:
290
AN:
68028
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00392
Hom.:
4
Bravo
AF:
0.00300
EpiCase
AF:
0.00442
EpiControl
AF:
0.00504

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Cryptosporidiosis-chronic cholangitis-liver disease syndrome (3)
-
1
1
not provided (2)
-
1
-
IgE responsiveness, atopic;C3554687:Cryptosporidiosis-chronic cholangitis-liver disease syndrome (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
6.0
DANN
Benign
0.70
DEOGEN2
Benign
0.10
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0058
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L
PhyloP100
0.37
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.40
N
REVEL
Benign
0.087
Sift
Benign
0.37
T
Sift4G
Benign
0.090
T
Varity_R
0.025
gMVP
0.31
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs56148525;
hg19: chr16-27460020;
COSMIC: COSV100559768;
COSMIC: COSV100559768;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.